Qingqing Sang

Shanghai, 201620, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Corrigendum to "Dual-responsive drug delivery systems prepared by blend electrospinning" [Int. J. Pharm. 543(1-2) (2018) 1-7].

Corrigendum to "Dual-responsive drug delivery systems prepared by blend electrospinning" [Int. J. Pharm. 543(1-2) (2018) 1-7].

Journal: International journal of pharmaceutics
Published: May 16, 2026

Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer.

Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer.

Journal: Cancer research
Published: June 18, 2025

Deciphering of intra-tumoural heterogeneity and the interplay between metastasis-associated meta-program and myofibroblasts in gastric cancer.

Deciphering of intra-tumoural heterogeneity and the interplay between metastasis-associated meta-program and myofibroblasts in gastric cancer.

Journal: Clinical and translational medicine
Published: January 09, 2025

Super-enhancer Activates Master Transcription Factor NR3C1 Expression and Promotes 5-FU Resistance in Gastric Cancer.

Super-enhancer Activates Master Transcription Factor NR3C1 Expression and Promotes 5-FU Resistance in Gastric Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 02, 2024

Targeting CBP revers chemoresistance to 5-FU of CDX2/REG4 double-positive gastric cancer.

Targeting CBP revers chemoresistance to 5-FU of CDX2/REG4 double-positive gastric cancer.

Journal: Clinical and translational medicine
Published: July 15, 2024

Identification and validation of platinum resistance signature in gastric cancer.

Identification and validation of platinum resistance signature in gastric cancer.

Journal: Cancer cell international
Published: June 24, 2024

SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer.

SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer.

Journal: EBioMedicine
Published: February 20, 2024

Characterization of alternative splicing events and prognostic signatures in gastric cancer.

Characterization of alternative splicing events and prognostic signatures in gastric cancer.

Journal: Cancer cell international
Published: January 24, 2024

Androgen receptor promotes cell stemness via interacting with co-factor YAP1 in gastric cancer.

Androgen receptor promotes cell stemness via interacting with co-factor YAP1 in gastric cancer.

Journal: Biochemical pharmacology
Published: August 03, 2023

BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC/PLCG1/Perk Axis.

BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC/PLCG1/Perk Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 14, 2023

Improving diagnosis and outcome prediction of gastric cancer via multimodal learning using whole slide pathological images and gene expression.

Improving diagnosis and outcome prediction of gastric cancer via multimodal learning using whole slide pathological images and gene expression.

Journal: Artificial intelligence in medicine
Published: April 25, 2023

VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer.

VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer.

Journal: EBioMedicine
Published: August 05, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026